← Back to all signals
RESEARCH PAPER ANALYSIS

Real-World Experiences Using Atezolizumab + Bevacizumab for the Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Study.

AI interpretation is pending for this paper.

Open original publication →
PMID40507295
JournalCancers
Publication Date2025-05-29
Ingested2026-08-02 12:04 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

Objective: This study aimed to evaluate the characteristics, clinical outcomes, and resource use of patients with unresectable hepatocellular carcinoma (uHCC) treated with first-line (1L) atezolizumab plus bevacizumab (A+B) at five United States (US) institutions: the Mayo Clinic, Houston Methodist, Moffitt Cancer Center, Mays Cancer Center, and University of Arizona. Methods: Treating oncologists extracted data from medical charts of patients with uHCC who were treated with A+B after 1 January 2019. Real-world progression-free survival (rwPFS) and overall survival (OS) were assessed using the Kaplan-Meier method for the overall cohort and for a "trial-like" subgroup with characteristics similar to those in the IMbrave150 trial (Eastern Cooperative Oncology Group Performance Status [ECOG PS] 0-1, Child-Pugh [CP] class A, albumin-bilirubin grade 1-2). Results: Of the 300 patients in the overall cohort (median age of 68 years; 12% ECOG PS ≥ 2; 73% CP A; 26% CP B; median follow-up of 8.7 months), the median rwPFS was 6.8 (95% confidence interval [CI]: 5.8, 8.4) months, and the median OS was 14.4 (95% CI: 12.3, 18.2) months. In the trial-like subgroup (n = 194), the median rwPFS was 8.8 (95% CI: 7.6, 12.1) months and the median OS was 19.5 (95% CI: 14.6, 24.7) months. A significantly lower proportion of patients with CP A compared with CP B (39.7% vs. 73.4%) experienced hospitalization within one year of A+B initiation, whereas hospitalizations due to treatment-related adverse events were similar. Conclusions: This study provides insights into the real-world effectiveness of 1L A+B in a diverse US patient cohort, with results from trial-like patients supporting the reproducible efficacy of A+B in clinical practice.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Global Trends in Sun Safety and Skin Cancer Prevention Education Among Adolescents: A Bibliometric Analysis. Cureus 58.0 2 Development and Validation of an Interpretable Machine Learning Model for Predicting Early Pulmonary Metastasis Risk in Osteosarcoma. Cancer medicine 66.3 3 Financial toxicity among families of children with cancer: a qualitative systematic review and meta-aggregation. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 77.52 4 Evaluation and Management of Suspected Mucinous Adnexal Masses in Children and Adolescents: A Practice-Focused Review. Journal of pediatric and adolescent gynecology 59.0 5 Acute Myeloid Leukemia Involving the Skin. Journal of cutaneous pathology 54.0 6 [Analysis and prediction study on the burden of malignant neoplasms of bone and articular cartilage in East Asian countries from 1990 to 2023]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 40.9 7 Retinoblastoma Metastatic to Bone: Case Series and Literature Review. Journal of radiology case reports 53.4 8 Pediatric Plantar Malignant Melanoma, Subungual Melanoma, and Spitzoid Melanoma: A Case Series of Rare Pediatric Melanomas. The Journal of clinical and aesthetic dermatology 48.5 9 Inborn errors of immunity and mortality: 10 years of single-center experience. Allergologia et immunopathologia 60.5 10 Regional Diversity of Human Papillomavirus Genotypes in Southeastern Brazil: Implications for Cervical Cancer Screening. Journal of medical virology 61.0 11 Epidemiology and Survival Determinants of Monomorphic Epitheliotropic T-Cell Lymphoma: A Pooled Patient-Level Dataset Analysis. Hematological oncology 74.52 12 Knowledge, attitudes, and practices regarding Helicobacter pylori-induced gastric ulcers and cancers among Saudi residents: a nationwide web-based survey. Frontiers in public health 70.4 13 Adult psychological outcomes among women with different adolescent PCOS presentations. Frontiers in endocrinology 59.5 14 Computational insights into synergistic mechanisms of PD-901 and 5-azacitidine targeting PTPN11 (SHP2) E76K mutation in juvenile myelomonocytic leukemia. Frontiers in bioinformatics 62.85 15 Clinical evidence and biological mechanisms linking obesity to adverse outcomes in pediatric and adolescent acute lymphoblastic leukemia. Frontiers in oncology 68.95 16 [Comparison of inpatient disease statistics based on two coding rules]. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 61.9 17 Serum HMGB3 and PCSK9 Levels as Predictors of Early Treatment Response in Pediatric Mycoplasma pneumoniae Pneumonia: A Single-Center Prospective Cohort Study. International journal of general medicine 79.26 18 Prevalence and penetrance of heritable retinoblastoma in two adult population cohorts: implications for genomic newborn screening. European journal of human genetics : EJHG 65.5 19 A mixed methods study of adolescent and young adult cancer survivors and their utilization of a survivorship clinic: Barriers and facilitators. Journal of cancer survivorship : research and practice 65.9 20 Perinatal Characteristics of Japanese Children With Infantile Hemangioma: A Questionnaire-Based Case-Control Study. The Journal of dermatology 67.0 21 Efficacy of celecoxib and methotrexate-vinblastine regimen in desmoid-type fibromatosis: A retrospective cohort study. Medicine 76.0 22 The safety and efficacy of different anti-tuberculosis regimens containing Lzd for RR/MDR/Pre-XDR-TB patients in China. Medicine 68.2 23 Nursing care of a pediatric patient with anti-NMDAR encephalitis complicated by secondary epilepsy: A case report. Medicine 61.1 24 Cardiac involvement in neurofibromatosis type 1: real-world baseline and follow-up findings from a tertiary single-center cohort. European journal of pediatrics 62.9 25 Multimodal clinical-radiomic-deep learning model for preoperative classification of pediatric pineal region tumors. Neuroradiology 70.4 26 Precision medicine for pediatric gliomas. Current opinion in oncology 80.34 27 Parental distress - a predictor of treatment adherence in pediatric neuroblastoma: a cross-sectional study of chinese families. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 62.24 28 Integrating optimal patient-centered care: patient- and family-reported experiences after complex treatment for rare diseases. World journal of pediatrics : WJP 63.94 29 [Guidelines for the diagnosis and treatment of hemophagocytic lymphohistiocytosis (2026 edition)]. Zhonghua yi xue za zhi 73.84 30 Cranial MRI in Girls With Central Precocious Puberty: Clinical Characteristics and Predictors of Abnormal Findings. Saudi medical journal 69.8 31 Diffuse midline glioma, H3 K27-altered, forming a suprasellar mass: A case report. Radiology case reports 51.9 32 Integrating immunophenotyping and morphology in the diagnosis of acute leukemia at the National Oncology Center, Sana'a, Yemen. The Libyan journal of medicine 61.0
PATIENT-FRIENDLY SUMMARY

Real-World Experiences Using Atezolizumab + Bevacizumab for the Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Study.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic